ACE2 and viral infectious disease: Our method is based on the reactivity of the major classes of antibodies, namely, IgG, IgM, and IgA toward the immunogenic RBD and NP proteins of the virus, and their ability to specifically inhibit the interactions of RBD with ACE2 and thus potentially neutralize viral infection (Fig. 1a).